What position did Corient Private Wealth LP take in Cabot Corporation, and what was its value?

Corient Private Wealth LP acquired a new stake in Cabot Corporation (NYSE:CBT) by purchasing 12,554 shares valued at approximately $1.14 million during the second quarter.

What is the current analyst consensus rating and price target for Cabot Corporation?

Analysts have issued a consensus 'Hold' rating for Cabot Corporation with an $89.00 price target.

Corient Private Wealth LP Takes Position in Cabot Corporation

Sep 5, 2026

Corient Private Wealth LP acquired a $1.14 million stake in specialty chemicals firm Cabot Corporation during Q2. Analysts maintain a consensus Hold rating with an $89 target despite recent insider selling by CEO Sean Keohane.

MarketBeat

2026-08-20

Denali Advisors LLC Reduces Stake in Cabot Corporation

2026-08-25

After $7.9M stock sale, Cabot (NYSE: CBT) insider plans another trade

2026-09-01

Manufacturers Life Insurance Company Acquires 47,211 Shares of Cabot Corporation

2026-09-05

Corient Private Wealth LP Takes Position in Cabot Corporation

Corient Private Wealth LP Takes Position in Cabot Corporation

FAQ